ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Allergy Therapeutics Plc

Allergy Therapeutics Plc (AGY)

5.20
0.00
(0.00%)
Cerrado 03 Diciembre 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
5.20
Postura de Compra
5.00
Postura de Venta
5.50
Volume Operado de la Acción
1,211,588
5.10 Rango del Día 5.26
1.88 Rango de 52 semanas 6.05
Capitalización de Mercado [m]
Precio Anterior
5.20
Precio de Apertura
5.25
Última hora de negociación
Volumen financiero
63,166p
Precio Promedio Ponderado
5.2135
Volumen promedio (3 m)
367,781
Acciones en circulación
4,766,439,938
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-6.25
Beneficio por acción (BPA)
-0.01
turnover
55.2M
Beneficio neto
-40.22M

Acerca de Allergy Therapeutics Plc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
West Sussex, Gbr
Fundado
-
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 5.20p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 1.88p to 6.05p.

Allergy Therapeutics currently has 4,766,439,938 shares in issue. The market capitalisation of Allergy Therapeutics is £247.85 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -6.25.

AGY Últimas noticias

IN BRIEF: Allergy Therapeutics treats first patient in allergy trial

ics PLC - Sussex, England-based biotechnology company - Treats its first patient in the third phase of its paediatric ...

Allergy Therapeutics PLC First Patient Dosed in G308 Paediatric Trial

Allergy Therapeutics PLC 27 November 2024     Allergy Therapeutics plc ("Allergy Therapeutics", "ATL" or the "Group")   Allergy Therapeutics announces first patient treated in G308 Phase III...

Allergy Therapeutics PLC Submission of MAA for Grass MATA MPL

Allergy Therapeutics PLC 25 November 2024   Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group")   Allergy Therapeutics Submits Marketing Authorisation Application for Grass MATA...

Allergy Therapeutics PLC Notice of 2024 Annual General Meeting

Allergy Therapeutics PLC 21 November 2024   Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company")   Notice of 2024 Annual General Meeting     21 November 2024 - Allergy...

Allergy Therapeutics annual loss narrows thanks to reduced expenses

Allergy Therapeutics PLC on Wednesday said it narrowed its loss during its most recent financial year despite a decli ...

Allergy Therapeutics PLC Audited Preliminary Results 2024

Allergy Therapeutics PLC 06 November 2024       Allergy Therapeutics PLC ("Allergy Therapeutics" or the "Group")     Audited Preliminary Results for the Year ended 30 June 2024   -    ...

Allergy Therapeutics enrols candidates for grass pollen allergy trial

Allergy Therapeutics PLC on Monday revealed that the first candidates have been enrolled in its phase III paediatric ...

Allergy Therapeutics PLC Commencement of Phase III Paediatric Trial

Allergy Therapeutics PLC 21 October 2024       Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group")   Allergy Therapeutics commences Phase III paediatric trial for Grass MATA MPL  ...

Allergy Therapeutics shares surge as enters into secured loan facility

Allergy Therapeutics PLC shares rallied on Wednesday after it announced a funding update with an alternative asset ma ...

Allergy Therapeutics PLC Update on funding

Allergy Therapeutics PLC 16 October 2024     Allergy Therapeutics plc ("Allergy Therapeutics", the "Group" or "Company")     Update on funding   16 October 2024 Allergy Therapeutics plc (AIM:...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.05-0.9523809523815.255.555.065711305.25784236DE
40.2455.6254107035.35709138DE
121.1528.39506172844.055.623.953677814.97726713DE
261.1528.39506172844.056.053.884926735.13471844DE
523.25166.6666666671.956.051.886657713.58102859DE
156-30.3-85.352112676135.535.50.854960084.29074094DE
260-6.3-54.782608695711.5400.854333449.17367593DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SCGLSealand Capital Galaxy Limited
0.54p
(80.00%)
36.26M
OBDOxford Biodynamics Plc
2.11p
(55.15%)
8.3M
MIRIMirriad Advertising Plc
0.18p
(33.33%)
23.04M
CLCOCloudcoco Group Plc
0.26p
(30.00%)
3.42M
IESInvinity Energy Systems Plc
15.00p
(27.66%)
4.57M
ZNTZentra Group Plc
3.50p
(-36.36%)
221.85k
UOGUnited Oil & Gas Plc
0.125p
(-34.21%)
123.45M
SYSSysgroup Plc
21.50p
(-24.56%)
788.98k
ADAAdams Plc
3.50p
(-22.22%)
25k
DSMDowning Strategic Micro-cap Investment Trust Plc
3.70p
(-21.28%)
22.32k
ORCPOracle Power Plc
0.0525p
(-7.89%)
3.65B
NTVONativo Resources Plc
0.0023p
(-8.00%)
1.51B
SYMESupply@me Capital Plc
0.0031p
(-10.14%)
1.11B
KEFIKefi Gold And Copper Plc
0.524p
(-19.63%)
567.23M
ENETEthernity Networks Ltd
0.1425p
(18.75%)
551.92M
GrantHorvat1 GrantHorvat1 58 segundos hace
Thinking we are very very close to Gvsi ascending to new heights for 2025. In a matter of 3 weeks the 4th Q of 2024 and the 8th Q of filed Financials will be complete and George can finally put his plan into motion here. I don't think people realize how close we are to pennyland.
GVSI
mascale mascale 1 minuto hace
I can acknowledge that Senator-Elect Schiff can see a major contribution of Southern California culture to world civilizations--a paid parking lot--across the street--from Burbank City Hall. My grandfather's building is due South--Beautiful Downtown Burbank, 1920. Grandpa had been friends with Mul
HIRU
Sammy 967 Sammy 967 1 minuto hace
One thing is stopping me from purchasing the shares is uncertainty about bringing the share price above the dollar to avoid delisting. I have a feeling that they will reverse split soon. I don't see any other solution for that. Hope they have some plan. 
AMRN
don estaban don estaban 2 minutos hace
I was just going to write you and see if that was you do you think those large blocks are real?
MVNT
capgain capgain 2 minutos hace
It was very sad hearing about him, he was a long time Ihubber for sure.
diamondguru-one diamondguru-one 3 minutos hace
I just sold all my dead beats and backed up the truck on this play.....NASA DEAL along is $4.00 easy
KULR
Mark Mark 3 minutos hace
$APDN .17, give us .20+ please
APDN
ignatiusrielly35 ignatiusrielly35 3 minutos hace
I agree with you. I'd go with Amazon only for an established drug that the pharma is already marketing. I would not go with Amazon for a new drug, with a novel MOA, that the pharma (Anavex) has no ability to market on its own. 
AVXL
SPARK SPARK 3 minutos hace
lol~
Risk vs Reward Risk vs Reward 3 minutos hace
I'm very big on Tesla too but do you have some new source to add the the conjecture we already think might happen ? Just asking... cause damn that with be sweet 
KULR
dcwisc dcwisc 3 minutos hace
://www.youtube.com/watch?v=X4F2XLHJP6A
NBRI
jimr1717 jimr1717 3 minutos hace
MOTORCYCLIST DIES IN CRASH ON 91ST STREET IN TULSA
Tulsa Police are investigating a fatal motorcycle crash early Tuesday morning.
Tuesday, December 3rd 2024, 4:38 am
By: News On 6

https://www.news9.com/story/674edf4c4e8bb8f412af5197/motorcyclist-dies-in-crash-on-9
TSLA
trading.jeff trading.jeff 4 minutos hace
I'm long and bullish, as you know, but this is a fluff article. Where are the fins???? Where is the OS reduction????

$APRU
APRU
Scope08 Scope08 4 minutos hace
This is a good example....a "sales report" was posted today. Seemingly good news.
I discounted it until I see further confirmation, didn't rah rah comment on it, and I moved on.

TP however, seems to be unnerved by it's posting....because it doesn't fit in with his narrative.
LWLG
capgain capgain 4 minutos hace
It was a crazy one, hard on the blood pressure lol
konshe konshe 4 minutos hace
Why are you here? If you don't like the company, just leave, no need waste your time to bashing stock.
CBDL
Stinger2014 Stinger2014 4 minutos hace
So now you’re going down?? lol 😂
CGAC
3331 3331 5 minutos hace
BIEL #3 BREAKOUT BOARD, GOLDEN CROSS BLUE SKY BREAKOUT, GONNA RUN LIKE 2021!
Risk vs Reward Risk vs Reward 5 minutos hace
Everybody's getting in position for the run of a lifetime 
KULR
coolhandluke88 coolhandluke88 5 minutos hace
I just came back to see if the millions of shares I had from flipping this thing years ago would ever be worth anything. Answer appears to be hell no. Only people here or a bunch of idiots. No need to come back. I will go back to the big boards were I flipped ATIP for $15000 this am. 1.80 to 2.4
ATIP
al44 al44 5 minutos hace
When the light shines-

https://media.gettr.com/group8/getter/2024/12/03/18/f9012a52-cbf4-ae7b-22a7-e4b60995db17/719ff586948a554ed229264ce4a2556c_768x0.png
silvr_surfr silvr_surfr 5 minutos hace
Maybe we will get some news ahead of tomorrow's Piper Sandler Healthcare Conference. Probably not.
ANIP
linkvest linkvest 5 minutos hace
They want the 9s. They are trying to walk it down to grab up the 9s that might fall.
RDAR
Peace1965 Peace1965 5 minutos hace
X is the best place to post.. Lakota wouldn’t show his face there..
INQD

Su Consulta Reciente

Delayed Upgrade Clock